Similar articles

• Gene expression in the mammalian cochlea: a study of multiple vector systems.

  Staecker H, Li D, O'Malley BW Jr, Van De Water TR. Staecker H, et al. Acta Otolaryngol. 2001 Jan;121(2):157-63. doi: 10.1080/000164801300043307. Acta Otolaryngol. 2001. PMID: 11349769
• Hyaluronic acid pretreatment for Sendai virus-mediated cochlear gene transfer.

  Kurioka T, Mizutari K, Niwa K, Fukumori T, Inoue M, Hasegawa M, Shiotani A. Kurioka T, et al. Gene Ther. 2016 Feb;23(2):187-95. doi: 10.1038/gt.2015.94. Epub 2015 Sep 11. Gene Ther. 2016. PMID: 26361273
• Gene therapy for sensorineural hearing loss.

  Chien WW, Monzack EL, McDougald DS, Cunningham LL. Chien WW, et al. Ear Hear. 2015 Jan;36(1):1-7. doi: 10.1097/AUD.0000000000000088. Ear Hear. 2015. PMID: 25166629 Review.
• Establishment of a model of cochlear lesions in rats to study potential gene therapy for sensorineural hearing loss.

  Wang Y, Qiao L, Chen Y, Wen L, Yue B, Qiu J, Wu S. Wang Y, et al. Int J Pediatr Otorhinolaryngol. 2015 Dec;79(12):2147-54. doi: 10.1016/j.ijporl.2015.09.037. Epub 2015 Nov 11. Int J Pediatr Otorhinolaryngol. 2015. PMID: 26574172
• [Feasibility of drug and gene therapy for sensorineural hearing loss].

  Kanzaki S. Kanzaki S. Nihon Yakurigaku Zasshi. 2013 Apr;141(4):188-90. doi: 10.1254/fpj.141.188. Nihon Yakurigaku Zasshi. 2013. PMID: 23575422 Review. Japanese. No abstract available.